Comparison of Propofol, Propofol-Remifentanil, and Propofol-Fentanyl Administrations with Each Other Used for the Sedation of Patients to Undergo ERCP

Table 1

Demographic and clinical features of the patients according to the groups.

Variables	Group I	Group II	Group III	value
Age	51.6 ± 12.9	52.1 ± 16.4	50.3 ± 13.3	0.885
Gender M/F	18/12	18/12	11/19	0.113
Weight	73.8 ± 16.7	72.9 ± 11.8	69.1 ± 12.7	0.391
ASA 1/2/3	14/12/4	10/16/4	10/20/0	0.649
Diagnosis				0.195
Liver pathology	16 (%53.3)	19 (%63.3)	23 (%76.7)
Pancreas pathology	4 (%13.3)	6 (%20.0)	4 (%13.3)
Others	10 (%33.3)	5 (%16.7)	3 (%10.0)
Additional disease	14 (%46.7)	19 (%63.3)	18 (%60.0)	0.387
Process time	25 (15–50)	25 (15–50)	25 (15–50)	0.595